41 Followers on Owler

Celltrion

is a South Korea-based pharmaceutical firm that develops and commercializes medicinal drugs for the treatment of diseases such as cancer and autoimmune... Read more
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Celltrion

is a South Korea-based pharmaceutical firm that develops and commercializes medicinal drugs for the treatment of diseases such as cancer and autoimmune... Read more
Celltrion CEO: Kee Woo-sung

CEO

Kee Woo-sung

CEO Approval Rating

89/100

2002

PublicMerged with Celltrion Healthcare Co., Ltd.Korea Exchange068270

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
2834 NAICS listing

Annual Revenue
$2.5B
Employees
2,916
Acquisitions
4
Investments
1

News

Acquisition
May 12, 2026
Korea Biomedical Review
Celltrion acquired Laboratoire Gifrer for undisclosed amount
Product Launch
Apr 28, 2026
Korea Biomedical Review
Celltrion launches Avtozma in Japan, entering tocilizumab market as first mover

Celltrion Competitors

1Kite Pharma
2Sorrento
3Hanmi Pharm
43SBIO
5Juno Therapeutics
6Daewoong
7Innovent Biologics
8Tocagen
9Apple
10Roche
Unlock 10 + competitors

Trending Companies